NP vs REGN · rev $44.4M vs P/E 14, rev $14.34B
Neptune Insurance Holdings Inc. (NP) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Neptune Insurance Holdings Inc. (NP) is a insurance brokers company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported NP revenue for 2025-09-30 was $44.4M. Net income was $11.5M. Revenue was up 31.2% from 2024-09-30 to 2025-09-30. NP currently screens at market cap $3.81B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
NP currently screens at market cap $3.81B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the NP and REGN stock pages for the full models.
Not investment advice.